For example, Vessillieret al. used immunomodulatory peptides fused via an MMP cleavage site to the latency-associated peptide of TGF-β1 to limit inflammation in the collagen-induced arthritis model114. This evidence concerns the gene TGFB1 and arthritic joint disease.